Stock-based compensation and shareholders' equity (Tables)

12 Months Ended

Dec. 31, 2013

Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements

A combined summary of the status of the Company’s stock-settled awards under the 2011 Plan, including base shares for stock-settled stock appreciation rights and stock-settled stock unit awards is as follows:


	Year ended December 31, 2013
	Stock appreciation rights							Stock units
	Awards			Weighted average exercise price		Weighted average remaining contractual life		Awards			Weighted average remaining contractual life
Outstanding at beginning of year		13,530,642		$	37.33				1,165,054
Granted		3,458,325			59.38				42,651
Exercised		(3,178,297	)		27.45				(172,260	)
Cancelled		(854,576	)		40.30				(68,849	)

Outstanding at end of period		12,956,094		$	45.44		2.8		966,596			1.4

Exercisable at end of period		3,539,501		$	31.98		1.4		5,302			0.5

Weighted-average fair value of grants in 2013	$	13.47						$	58.90

Weighted-average fair value of grants in 2012	$	11.28						$	54.85

Weighted-average fair value of grants in 2011	$	10.97						$	42.64

Summary of Range of Exercise Prices


Range of SSAR base prices	Awards outstanding		Weighted average exercise price		Awards exercisable		Weighted average exercise price
$20.00–$30.00		1,080,160		23.44		1,055,863		23.32
$30.01–$40.00		2,524,525		33.28		1,733,104		32.67
$40.01–$50.00		4,186,568		42.97		746,597		42.50
$50.01–$60.00		4,815,641		57.51		3,937		54.17
$60.01–$70.00		349,200		64.55		—		—

Total		12,956,094	$	45.44		3,539,501	$	31.98

Summary of Weighted Average Valuation Inputs

A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of stock-settled stock appreciation rights awards granted in the periods indicated is as follows:


	Year ended December 31,
	2013			2012			2011
Expected term		4.1 years			3.7 years			4.2 years
Expected volatility		27.2	%		28	%		30	%
Expected dividend yield		0.0	%		0.0	%		0.0	%
Risk-free interest rate		0.7	%		0.6	%		1.6	%

Effects of Changes in DaVita Inc's Ownership Interest on Company's Equity

The effects of changes in DaVita HealthCare Partners Inc.’s ownership interest on the Company’s equity are as follows:


	Year ended December 31,
	2013			2012			2011
Net income attributable to DaVita HealthCare Partners Inc.	$	633,446		$	536,017		$	478,001

(Decrease) increase in paid-in capital for sales of noncontrolling interest		(1,442	)		1,064			(1,299	)
Decrease in paid-in capital for the purchase of a noncontrolling interest		(3,119	)		(20,694	)		(9,486	)

Net transfer to noncontrolling interests		(4,561	)		(19,630	)		(10,785	)

Change from net income attributable to DaVita HealthCare Partners Inc. and transfers to noncontrolling interests	$	628,885		$	516,387		$	467,216

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details